New webinar to focus on TCE chemical and Parkinson’s disease
At an upcoming free webinar, hosted by Synapticure, experts will discuss how the chemical trichloroethylene or TCE — a widely-used…
Articles by Marisa Wexler, MS
More support needed for people with Parkinson’s and anxiety: Study
Anxiety is a common problem for people with Parkinson’s disease and can cause substantial difficulties in patients’ day-to-day lives,…
Camp Lejeune TCE contamination and Parkinson’s risk analyzed
The risk of Parkinson’s disease is increased among people who have been exposed to the chemical trichloroethylene (TCE), according…
BioVie exploring potentially pivotal trial for NE3107
BioVie is exploring a potentially pivotal Phase 3 clinical trial to test its experimental oral therapy NE3107 in people with…
Worm study links gut bacteria to alpha-synuclein clumping
Bacteria in the group Desulfovibrio may promote the disease-driving clumping of alpha-synuclein protein in Parkinson’s disease, a new study…
Inflammatory protein ASC may be therapeutic target in Parkinson’s
An inflammatory protein called ASC was found in laboratory models to help accelerate the toxic spread of alpha-synuclein through the…
Vaxxinity shares update about potential vaccine UB-312
Results from a Phase 1 clinical trial testing the experimental vaccine UB-312 in people with Parkinson’s disease are expected…
Parkinson’s-like symptoms found to be common in ‘oldest old’ in study
Many elderly people who do not have Parkinson’s disease nonetheless experience some Parkinson’s-like symptoms, especially slowness of movement, a…
Novel machine learning tool IDs early Parkinson’s biomarkers
A novel machine learning tool, called CRANK-MS, was able to identify, with high accuracy, people who would go on to…
High-intensity boxing program seen as safe, feasible in Parkinson’s
A high-intensity boxing program can be a safe way for people with Parkinson’s disease to exercise both mind and…